Understanding coupling between bone resorption and formation: are reversal cells the missing link?

Bone remodeling involves sequential phases of resorption and formation, yet the transitional phase between these steps remains poorly understood. Current knowledge identifies osteoclasts as responsible for resorption and osteoblasts for formation. However, the mechanisms linking these two processes are not fully elucidated. Reversal cells, which appear to bridge resorption and formation, have been observed but remain functionally undefined. Their role in diseases like postmenopausal osteoporosis is unclear. Prior research has shown that osteoclasts create eroded surfaces, which are then occupied by reversal cells. The nature of these cells has not been clearly established. Their potential dysfunction in bone diseases has not been investigated. This gap motivated the current study to explore reversal cell characteristics and their relevance to bone loss.

This study aimed to investigate the identity and functional status of reversal cells during bone remodeling. The specific problem addressed was the lack of understanding about how reversal cells contribute to the transition from resorption to formation. The motivation stemmed from the observation that these cells cover most eroded surfaces but remain unidentified. The study sought to determine whether reversal cells express osteoblast markers or monocytic markers. It also aimed to assess whether these cells show signs of physiological arrest. The goal was to link reversal cell status to bone loss in osteoporosis. The study tested whether reversal cell dysfunction correlates with decreased bone volume and formation markers. It further compared reversal cell presence in osteoporosis versus hyperparathyroidism.

The study used histomorphometry and immunohistochemistry (IHC) on human iliac bone biopsy samples. Histomorphometry quantified reversal cell coverage and bone volume. IHC assessed reversal cell expression of osteoblast and monocytic markers. The researchers analyzed reversal cell prevalence in postmenopausal osteoporosis and primary hyperparathyroidism. They compared trabecular bone volume, osteoid surfaces, and osteoblast surfaces between the two conditions. The study evaluated whether reversal cells showed signs of physiological arrest. It also examined the correlation between reversal cell prevalence and bone loss indicators. The methods focused on identifying reversal cell markers and assessing their functional status. The approach combined morphological and immunological analyses to explore reversal cell roles.

Reversal cells showed immunoreactivity for osteoblast markers but not monocytic markers. A subpopulation of reversal cells exhibited characteristics of physiological arrest. These arrested cells were more prevalent in postmenopausal osteoporosis. Their presence correlated with reduced trabecular bone volume. Osteoid and osteoblast surfaces were also decreased in these cases. Reversal cells were nearly absent in primary hyperparathyroidism. In that condition, the transition from resorption to formation occurred efficiently. The findings suggest that arrested reversal cells may reflect incomplete remodeling cycles.

The authors propose that bone loss in postmenopausal osteoporosis involves a failure at the reversal phase, not just the formation phase. Reversal cells appear to play a role in preparing resorbed surfaces for formation. Their arrested state may prevent successful transition to bone formation. The study suggests that reversal cell dysfunction contributes to bone loss. The findings indicate that reversal cells are distinct from monocytic cells. They express osteoblast markers, supporting a role in bone formation. The study highlights the need to investigate reversal cell function further. The authors suggest that targeting reversal cell activity could be a novel therapeutic approach.